The company said net sales for Q3 2025 were $1,892.6 million, an increase of $184.0 million or 10.8% compared with the prior year period. It cited organic sales growth of 4%, acquisitions of 6% and a foreign currency translation effect of 1% as components of the increase.

10-QQuarterly reportFiled Oct 30, 2025Period of report Sep 30, 2025Summary published (UTC) Oct 11, 2026

Key points

AI summary

The company said net sales for Q3 2025 were $1,892.6 million, an increase of $184.0 million or 10.8% compared with the prior year period. It cited organic sales growth of 4%, acquisitions of 6% and a foreign currency translation effect of 1% as components of the increase.
The company said consolidated operating income for Q3 2025 was $488.4 million or 25.8% of net sales, an increase of $445.9 million or 26.1% compared with the prior year period. It explained that the dilutive impact of recent acquisitions of 80 basis points and acquisition-related costs of 40 basis points negatively impacted operating margins, which increased 9.5% compared with the prior year period.
AMETEK said net income for Q3 2025 was $371.4 million, an increase of 9.2% compared with $340.2 million in the prior-year quarter, and diluted earnings per share were $1.60, compared with $1.47 per diluted share in the prior-year quarter.
AMETEK said cash provided by operating activities for the first 9 months of 2025 was $1,217.5 million, a decrease compared with $1,278.8 million in the prior-year period, and free cash flow was $1,144.2 million. The company paid $933.2 million, net of cash acquired, to purchase Kern Microtechnik and FARO Technologies during the period.

Key figures

Quarter ended September 30, 2025

Revenue: $1.9B
Operating income: $488M
Net income: $371M
EPS: $1.60

From the XBRL financial data filed with the SEC · not processed by AI.

Summary

AI-written

Analysis scope · Management's discussion (MD&A)We analyzed the Management's Discussion and Analysis (MD&A) section. Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

Q3 2025 Net Sales and Components of Growth

The company said net sales for Q3 2025 were $1,892.6 million, an increase of $184.0 million or 10.8% compared with the prior year period. It cited organic sales growth of 4%, acquisitions of 6% and a foreign currency translation effect of 1% as components of the increase.

Source · Based on the MD&A text of the filing

Q3 Consolidated Operating Income and Acquisition-Related Effects

The company said consolidated operating income for Q3 2025 was $488.4 million or 25.8% of net sales, an increase of $445.9 million or 26.1% compared with the prior year period. It explained that the dilutive impact of recent acquisitions of 80 basis points and acquisition-related costs of 40 basis points negatively impacted operating margins, which increased 9.5% compared with the prior year period.

Source · Based on the MD&A text of the filing

Q3 Net Income and Diluted EPS

AMETEK said net income for Q3 2025 was $371.4 million, an increase of 9.2% compared with $340.2 million in the prior-year quarter, and diluted earnings per share were $1.60, compared with $1.47 per diluted share in the prior-year quarter.

Source · Based on the MD&A text of the filing

First 9 Months of 2025 Operating Cash Flow and Acquisition Spending

AMETEK said cash provided by operating activities for the first 9 months of 2025 was $1,217.5 million, a decrease compared with $1,278.8 million in the prior-year period, and free cash flow was $1,144.2 million. The company paid $933.2 million, net of cash acquired, to purchase Kern Microtechnik and FARO Technologies during the period.

Source · Based on the MD&A text of the filing

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.